At a Glance
| Dextroamphetamine | 3-FMA | |
|---|---|---|
| Class | Stimulants | Entactogen, Stimulants |
| Common Dose (oral) | 10–16 mg | 20–35 mg |
| Total Duration | 3.3–5.5 hrs | 2.8–6 hrs |
| Routes | insufflatedoral | oral |
Dextroamphetamine, a Stimulants, and 3-FMA, a Entactogen, Stimulants, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Dextroamphetamine is classified as a Stimulants while 3-FMA is a Entactogen, Stimulants, meaning they approach altered states through different pharmacological mechanisms. They share 3 documented effects in common, with 13 effects unique to Dextroamphetamine and 2 unique to 3-FMA. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| Dextroamphetamine | 3-FMA | |
|---|---|---|
| Class | Stimulants | Entactogen, Stimulants |
| Common Dose (oral) | 10–16 mg | 20–35 mg |
| Total Duration | 3.3–5.5 hrs | 2.8–6 hrs |
| Routes | insufflatedoral | oral |
| Effects | 16 documented | 5 documented |
| Interaction | Caution | |
| Level | Dextroamphetamine | 3-FMA |
|---|---|---|
| Threshold | 3.75 mg | 5 mg |
| Light | 3.75–10 mg | 10–20 mg |
| Common | 10–16 mg | 20–35 mg |
| Strong | 16–30 mg | 35–50 mg |
| Heavy | 30 mg | 50 mg |
| Level | Dose |
|---|---|
| Threshold | 3 mg |
| Light | 3–7.5 mg |
| Common | 7.5–12 mg |
| Strong | 12–21.5 mg |
| Heavy | 21.5 mg |
Dextroamphetamine
Total: 6 hrs – 8 hrs
3-FMA
Total: 3 hrs – 7 hrs
Total: 3 hrs – 6 hrs
Increased cardiovascular strain and neurotoxicity risk